See also this year's filing and all EDGAR filings for this company.
PDF Report 0000847464_2016_Spring_Pharmaceutical_Group_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0000847464, Spring Pharmaceutical Group INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 15,393,272 |
| 2 | PropertyPlantAndEquipmentNet | 12,864,161 |
| 3 | remainder_Assets | 48,900,442 |
| 4 | LiabilitiesCurrent | 1,748,384 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 701,613 |
| 9 | ResearchAndDevelopmentExpense | -2,046,701 |
| 10 | remainder_Expenses | 26,472,218 |
| 11 | remainder_Revenues | 35,752,468 |
| 12 | remainder_NetIncome | -303,945 |
| 13 | remainder_ComprehensiveNetIncome | -2,774,978 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 77,157,875 |
| 1 | Liabilities | 1,748,384 |
| 2 | Expenses | 25,127,130 |
| 3 | Revenues | 35,752,468 |
| 4 | StockholdersEquity | 75,409,491 |
| 5 | NetIncome | 10,321,393 |
| 6 | ComprehensiveNetIncome | 8,933,904 |
| 7 | BaseVar | 71,432,390 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.39 |
| 9 | EconomicCapitalRatio | 4.69 |
Edgar->Model Mapping
Feature Distribution
Change over Time
